KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $16.2 billion.

  • Merck's Other Accumulated Expenses fell 213.43% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 billion, marking a year-over-year decrease of 213.43%. This contributed to the annual value of $15.7 billion for FY2024, which is 45.67% down from last year.
  • Per Merck's latest filing, its Other Accumulated Expenses stood at $16.2 billion for Q3 2025, which was down 213.43% from $14.5 billion recorded in Q2 2025.
  • Merck's Other Accumulated Expenses' 5-year high stood at $16.5 billion during Q3 2024, with a 5-year trough of $11.9 billion in Q1 2021.
  • In the last 5 years, Merck's Other Accumulated Expenses had a median value of $14.2 billion in 2022 and averaged $14.2 billion.
  • In the last 5 years, Merck's Other Accumulated Expenses soared by 2159.11% in 2021 and then crashed by 943.13% in 2025.
  • Merck's Other Accumulated Expenses (Quarter) stood at $13.9 billion in 2021, then rose by 2.16% to $14.2 billion in 2022, then rose by 11.35% to $15.8 billion in 2023, then dropped by 0.46% to $15.7 billion in 2024, then grew by 3.13% to $16.2 billion in 2025.
  • Its Other Accumulated Expenses stands at $16.2 billion for Q3 2025, versus $14.5 billion for Q2 2025 and $12.8 billion for Q1 2025.